2019
DOI: 10.1016/j.scib.2019.04.034
|View full text |Cite
|
Sign up to set email alerts
|

ASAF: altered spontaneous activity fingerprinting in Alzheimer’s disease based on multisite fMRI

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
9

Relationship

4
5

Authors

Journals

citations
Cited by 27 publications
(12 citation statements)
references
References 104 publications
0
12
0
Order By: Relevance
“…We should notice that the image acquisition scanning protocols differ across different sites. Various fMRI scanning parameters (echo time, voxel size, scan time duration, etc.,) in different sites may result in the inconsistency of fALFF and ReHo (Li, Jin, et al, 2019); and various PET scanning parameters (injected FDG amount, dynamic scan time, etc.,) may also result in the inconsistency of FDG SUVR. Therefore, the deviations may appear when we calculated SUVR/fALFF (ρ) or SUVR/ReHo (ρ) in different sites.…”
Section: Discussionmentioning
confidence: 99%
“…We should notice that the image acquisition scanning protocols differ across different sites. Various fMRI scanning parameters (echo time, voxel size, scan time duration, etc.,) in different sites may result in the inconsistency of fALFF and ReHo (Li, Jin, et al, 2019); and various PET scanning parameters (injected FDG amount, dynamic scan time, etc.,) may also result in the inconsistency of FDG SUVR. Therefore, the deviations may appear when we calculated SUVR/fALFF (ρ) or SUVR/ReHo (ρ) in different sites.…”
Section: Discussionmentioning
confidence: 99%
“…Machine learning is an application of artificial intelligence that allows computers to learn automatically and improve from experience. It is one of today's most rapidly growing technical fields (13), which performs throughout science including health care (14) such as identification and classification for diseases like AD (15)(16)(17), traffic programming (18), and marketing apps designing (19), which allows us to process largescale, multidimensional, complex datasets in this information explosion of an era. Machine learning-based analysis of connectomic data created from neuroimaging studies in patients AD has been extensively studied in the literature (5,9,12,20,21).…”
Section: Introductionmentioning
confidence: 99%
“…As discussed in several previous studies [31,[45][46][47][48][49], cross-site validation is crucial for optimizing valid biomarkers and is particularly important for translational medicine. Hence, the classification analysis with independent site cross-validations to predict diagnostic status provides shreds of evidence that tdNCD can provide additional information as imaging biomarkers for AD.…”
Section: Discussionmentioning
confidence: 99%